Extraintestinal manifestations of Helicobacter pylori: A concise review

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 11950-11961

  Wong, Frank ^a   Rayner Hartley, Erin ^a   Byrne, Michael F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Immune thrombocytopenic purpura; Iron deficiency; Migraine; Rosacea; Urticaria

Indexed keywords

ALZHEIMER DISEASE; ASTHMA; BRAIN ISCHEMIA; CORONARY ARTERY DISEASE; ERADICATION THERAPY; FIBROMYALGIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSULIN RESISTANCE; IRON DEFICIENCY ANEMIA; METABOLIC SYNDROME X; MIGRAINE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; REVIEW; ROSACEA; STOMACH ADENOCARCINOMA; URTICARIA; ANIMAL; COMPLICATION; MICROBIOLOGY; PATHOGENICITY; PROGNOSIS; RISK FACTOR;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 84909620019     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.11950     Document Type: Review

References (158)

1. Lee R, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM. Wintrobe's Clinical hematology, Vol. 1 and 2. Philadelphia: Williams & Wilkins, 1998
2. Monzón H, Forné M, Esteve M, Rosinach M, Loras C, Espinós JC, Viver JM, Salas A, Fernández-Bañares F. Helicobacter pylori infection as a cause of iron deficiency anaemia of unknown origin. World J Gastroenterol 2013; 19: 4166-4171 [PMID: 23864779 DOI: 10.3748/wjg.v19.i26.4166]
3. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997; 277: 973-976 [PMID: 9091669 DOI: 10.1001/jama.1997. 03540360041028]
4. Coad J, Conlon C. Iron deficiency in women: assessment, causes and consequences. Curr Opin Clin Nutr Metab Care 2011; 14: 625-634 [PMID: 21934611 DOI: 10.1097/MCO.0b013 e32834be6fd]
5. Brittenham GM. Disorders of iron metabolism: Iron deficiency and overload. In: Hoffman R, BenZ EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, editors. Haematology: Basic Principles and Practice. New York: Churchill Livingston, 1995: 492
6. Conrad ME, Umbreit JN, Moore EG. Iron absorption and transport. Am J Med Sci 1999; 318: 213-229 [PMID: 10522550 DOI: 10.1097/00000441-199910000-00002]
7. Blecker U, Renders F, Lanciers S, Vandenplas Y. Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur J Pediatr 1991; 150: 560-561 [PMID: 1954961 DOI: 10.1007/BF02072207]
8. Annibale B, Marignani M, Monarca B, Antonelli G, Marcheggiano A, Martino G, Mandelli F, Caprilli R, Delle Fave G. Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med 1999; 131: 668-672 [PMID: 10577329 DOI: 10.7326/0003-4819-131-9-199911020-00006]
9. Sugiyama T, Tsuchida M, Yokota K, Shimodan M, Asaka M. Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection. Intern Med 2002; 41: 491-494 [PMID: 12135186 DOI: 10.2169/ internalmedicine.41.491]
10. Yoshimura M, Hirai M, Tanaka N, Kasahara Y, Hosokawa O. Remission of severe anemia persisting for over 20 years after eradication of Helicobacter pylori in cases of Ménètrier's disease and atrophic gastritis: Helicobacter pylori as a pathogenic factor in iron-deficiency anemia. Intern Med 2003; 42: 971-977 [PMID: 14606710 DOI: 10.2169/internalmedicine. 42.971]
11. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 2008; 13: 323-340 [PMID: 19250507 DOI: 10.1111/ j.1523-5378.2008.00617.x]
12. Valiyaveettil AN, Hamide A, Bobby Z, Krishnan R. Effect of anti-Helicobacter pylori therapy on outcome of irondeficiency anemia: a randomized, controlled study. Indian J Gastroenterol 2005; 24: 155-157 [PMID: 16204902]
13. Malik R, Guleria K, Kaur I, Sikka M, Radhakrishnan G. Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study. Indian J Med Res 2011; 134: 224-231 [PMID: 21911976]
14. Yuan W, Li Yumin D, Yang L. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol 2010; 45: 665-676 [PMID: 20201716 DOI: 10.3109/00365521003663670]
15. Zhang ZF, Yang N, Zhao G, Zhu L, Zhu Y, Wang LX. Effect of Helicobacter pylori eradication on iron deficiency. Chin Med J (Engl) 2010; 123: 1924-1930 [PMID: 20819579]
16. Huang X, Qu X, Yan W, Huang Y, Cai M, Hu B, Wu L, Lin H, Chen Z, Zhu C, Lu L, Sun X, Rong L, Jiang Y, Sun D, Zhong L, Xiong P. Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J 2010; 86: 272-278 [PMID: 20448223 DOI: 10.1136/pgmj.2009.089987]
17. Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY, Lin H, Cai MC, Chen ZW, Hu B, Wu LM, Jiang YB, Yan WL. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol 2010; 16: 886-896 [PMID: 20143469]
18. Papagiannakis P, Michalopoulos C, Papalexi F, Dalampoura D, Diamantidis MD. The role of Helicobacter pylori infection in hematological disorders. Eur J Intern Med 2013; 24: 685-690 [PMID: 23523153 DOI: 10.1016/j.ejim.2013.02.011]
19. Dickey W. Iron deficiency, gastric atrophy and Helicobacter pylori. Dig Liver Dis 2002; 34: 313-315 [PMID: 12118945 DOI: 10.1016/S1590-8658(02)80121-9]
20. Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle Fave G. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 2003; 52: 496-501 [PMID: 12631657 DOI: 10.1136/ gut.52.4.496]
21. Boyanova L. Role of Helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization. Future Microbiol 2011; 6: 843-846 [PMID: 21861616 DOI: 10.2217/fmb.11.75]
22. Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut 2011; 60: 1309-1316 [PMID: 21561874 DOI: 10.1136/ gut.2010.228874]
23. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection - the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/gutjnl-2012-302084]
24. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207 [PMID: 21325604 DOI: 10.1182/blood-2010-08-302984]
25. Tan HJ, Goh KL. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J Dig Dis 2012; 13: 342-349 [PMID: 22713083 DOI: 10.1111/j.1751-2980.2012.00599.x]
26. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878 [PMID: 9742983 DOI: 10.1016/S0140-6736(05)60004-9]
27. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009; 113: 1231-1240 [PMID: 18945961 DOI: 10.1182/blood-2008-07-167155]
28. Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG, Crowther MA. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica 2009; 94: 850-856 [PMID: 19483158 DOI: 10.3324/haematol.2008.005348]
29. Kikuchi T, Kobayashi T, Yamashita T, Ohashi K, Sakamaki H, Akiyama H. Eight-year follow-up of patients with immune thrombocytopenic purpura related toH. pyloriinfection. Platelets 2011; 22: 61-64 [PMID: 20942598 DOI: 10.3109/ 09537104.2010.515272]
30. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003; 124: 1846-1854 [PMID: 12806618 DOI: 10.1016/S0016-5085(03)00397-4]
31. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004; 124: 91-96 [PMID: 14675413 DOI: 10.1046/j.1365-2141.2003.04735.x]
32. Asahi A, Nishimoto T, Okazaki Y, Suzuki H, Masaoka T, Kawakami Y, Ikeda Y, Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest 2008; 118: 2939-2949 [PMID: 18654664]
33. Onat A, Sari I, Hergenc¸ G, Yazici M, Uyarel H, Can G, Sansoy V. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study. Metabolism 2007; 56: 348-356 [PMID: 17292723]
34. Lobo RA. Inflammation, coronary artery disease, and hormones. Menopause 2008; 15: 1036-1038 [PMID: 18779754 DOI: 10.1097/gme.0b013e318184c45a]
35. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-439 [PMID: 8011406 DOI: 10.1136/hrt.71.5.437]
36. Pieniazek P, Karczewska E, Duda A, Tracz W, Pasowicz M, Konturek SJ. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol 1999; 50: 743-751 [PMID: 10695556]
37. Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R, Kranig W, Nasseri R, Thale J, Hahn EG, Konturek SJ. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001; 33: 222-229 [PMID: 11407666 DOI: 10.1016/S1590-8658(01)80711-8]
38. Rogha M, Nikvarz M, Pourmoghaddas Z, Shirneshan K, Dadkhah D, Pourmoghaddas M. Is helicobacter pylori infection a risk factor for coronary heart disease? ARYA Atheroscler 2012; 8: 5-8 [PMID: 23056092]
39. Park MJ, Choi SH, Kim D, Kang SJ, Chung SJ, Choi SY, Yoon DH, Lim SH, Kim YS, Yim JY, Kim JS, Jung HC. Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver 2011; 5: 321-327 [PMID: 21927661 DOI: 10.5009/ gnl.2011.5.3.321]
40. Huang B, Chen Y, Xie Q, Lin G, Wu Y, Feng Y, Li J, Zhuo Y, Zhang P. CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease. Dig Dis Sci 2011; 56: 109-114 [PMID: 20503072 DOI: 10.1007/ s10620-010-1274-6]
41. Niccoli G, Franceschi F, Cosentino N, Giupponi B, De Marco G, Merra G, Conte M, Montone RA, Ferrante G, Bacà M, Gasbarrini A, Silveri NG, Crea F. Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis 2010; 21: 217-221 [PMID: 20389238 DOI: 10.1097/MCA.0b013e3283399f36]
42. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998; 316: 1130-1132 [PMID: 9552950 DOI: 10.1136/bmj.316.7138.1130]
43. Padmavati S, Gupta U, Agarwal HK. Chronic infections & amp; coronary artery disease with special reference to Chalmydia pneumoniae. Indian J Med Res 2012; 135: 228-232 [PMID: 22446866]
44. Schöttker B, Adamu MA, Weck MN, Müller H, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis 2012; 220: 569-574 [PMID: 22189198 DOI: 10.1016/j.atherosclerosis.2011.11.029]
45. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001; 32: 385-391 [PMID: 11157171 DOI: 10.1161/01.STR.32.2.385]
46. Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO. Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci 2009; 54: 1253-1256 [PMID: 18770033 DOI: 10.1007/s10620-008-0482-9]
47. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45: 1219-1222 [PMID: 15837252 DOI: 10.1016/ j.jacc.2005.01.019]
48. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, Graham DY, Genta RM. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002; 106: 430-434 [PMID: 12135941 DOI: 10.1161/01.CIR.0000024100.90140.19]
49. Chimienti G, Russo F, Lamanuzzi BL, Nardulli M, Messa C, Di Leo A, Correale M, Giannuzzi V, Pepe G. Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a). Clin Biochem 2003; 36: 359-365 [PMID: 12849867 DOI: 10.1016/S0009-9120(03)00063-8]
50. Kucukazman M, Yavuz B, Sacikara M, Asilturk Z, Ata N, Ertugrul DT, Yalcin AA, Yenigun EC, Kizilca G, Okten H, Akin KO, Nazligul Y. The relationship between updated Sydney System score and LDL cholesterol levels in patients infected with Helicobacter pylori. Dig Dis Sci 2009; 54: 604-607 [PMID: 18649137 DOI: 10.1007/s10620-008-0391-y]
51. McCune A, Lane A, Murray L, Harvey I, Nair P, Donovan J, Harvey R. Reduced risk of atopic disorders in adults with Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2003; 15: 637-640 [PMID: 12840675 DOI: 10.1097/00042737-200306000-00010]
52. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000; 55 Suppl 1: S2-10 [PMID: 10943631]
53. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198: 553-560 [PMID: 18598192 DOI: 10.1086/590158]
54. Corrado G, Luzzi I, Pacchiarotti C, Lucarelli S, Frediani T, Cavaliere M, Rea P, Cardi E. Helicobacter pylori seropositivity in children with atopic dermatitis as sole manifestation of food allergy. Pediatr Allergy Immunol 2000; 11: 101-105 [PMID: 10893012 DOI: 10.1034/j.1399-3038.2000.00028.x]
55. Oertli M, Müller A. Helicobacter pylori targets dendritic cells to induce immune tolerance, promote persistence and confer protection against allergic asthma. Gut Microbes 2012; 3: 566-571 [PMID: 22895083 DOI: 10.4161/gmic.21750]
56. Annagür A, Kendirli SG, Yilmaz M, Altintas DU, Inal A. Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumoniae, Mycoplasma pneumoniae and Helicobacter pylori. J Trop Pediatr 2007; 53: 313-318 [PMID: 17535826 DOI: 10.1093/tropej/fmm040]
57. Holster IL, Vila AM, Caudri D, den Hoed CM, Perez-Perez GI, Blaser MJ, de Jongste JC, Kuipers EJ. The impact of Helicobacter pylori on atopic disorders in childhood. Helicobacter 2012; 17: 232-237 [PMID: 22515362 DOI: 10.1111/j.1523-5378.2012.00934.x]
58. Wang Q, Yu C, Sun Y. The association between asthma and Helicobacter pylori: a meta-analysis. Helicobacter 2013; 18: 41-53 [PMID: 23067334 DOI: 10.1111/hel.12012]
59. Zhou X, Wu J, Zhang G. Association between Helicobacter pylori and asthma: a meta-analysis. Eur J Gastroenterol Hepatol 2013; 25: 460-468 [PMID: 23242126]
60. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752 [PMID: 16157765 DOI: 10.1161/ CIRCULATIONAHA.105.169404]
61. Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011; 16: 79-88 [PMID: 21435084 DOI: 10.1111/j.1523-5378.2011.00822.x]
62. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 2008; 103: 3005-3010 [PMID: 19086952 DOI: 10.1111/j.1572-0241.2008.02151.x]
63. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009; 14: 144-150 [PMID: 19751440 DOI: 10.1111/j.1523-5378.2009.00705.x]
64. Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, Gun BD, Borazan A, Ustundag Y. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 2005; 50: 2090-2093 [PMID: 16240220 DOI: 10.1007/s10620-005-3012-z]
65. Eshraghian A, Hashemi SA, Hamidian Jahromi A, Eshraghian H, Masoompour SM, Davarpanah MA, Eshraghian K, Taghavi SA. Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci 2009; 54: 1966-1970 [PMID: 19009348 DOI: 10.1007/s10620-008-0557-7]
66. Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 2009; 9: 299-314 [PMID: 19355912 DOI: 10.2174/156652409787847191]
67. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005; 90: 10-16 [PMID: 15483107 DOI: 10.1210/jc.2004-1330]
68. Roper J, Francois F, Shue PL, Mourad MS, Pei Z, Olivares de Perez AZ, Perez-Perez GI, Tseng CH, Blaser MJ. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab 2008; 93: 2350-2357 [PMID: 18397989 DOI: 10.1210/jc.2007-2057]
69. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and lowgrade inflammation. South Med J 2010; 103: 190-196 [PMID: 20134372 DOI: 10.1097/SMJ.0b013e3181cf373f]
70. Christodoulou DK, Milionis HJ, Pappa P, Katsanos KH, Sigounas D, Florentin M, Elisaf M, Tsianos EV. Association of Helicobacter pylori infection with cardiovascular disease - is it just a myth? Eur J Intern Med 2011; 22: 191-194 [PMID: 21402252 DOI: 10.1016/j.ejim.2010.11.010]
71. Dore MP, Bilotta M, Malaty HM, Pacifico A, Maioli M, Graham DY, Realdi G. Diabetes mellitus and Helicobacter pylori infection. Nutrition 2000; 16: 407-410 [PMID: 10869894 DOI: 10.1016/S0899-9007(00)00267-7]
72. Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004; 96: 1470-1476 [PMID: 15586651]
73. Naja F, Nasreddine L, Hwalla N, Moghames P, Shoaib H, Fatfat M, Sibai A, Gali-Muhtasib H. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 2012; 17: 444-451 [PMID: 23066847 DOI: 10.1111/j.1523-5378.2012.00970.x]
74. Lu YH, Yen HW, Lin TH, Huang CH, Lee KT, Wang WM, Wu DC, Voon WC, Lai WT, Sheu SH. Changes of coronary risk factors after eradication of Helicobacter pylori infection. Kaohsiung J Med Sci 2002; 18: 266-272 [PMID: 12355926]
75. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53: 693-700 [PMID: 14988254 DOI: 10.2337/ diabetes.53.3.693]
76. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334 [PMID: 11466099 DOI: 10.1001/jama.286.3.327]
77. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380-385 [PMID: 15262834 DOI: 10.1161/01.CIR.0000136581.59584.0E]
78. Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006; 29: 1058-1064 [PMID: 16644637 DOI: 10.2337/dc05-2068]
79. Howard BV, Best L, Comuzzie A, Ebbesson SO, Epstein SE, Fabsitz RR, Howard WJ, Silverman A, Wang H, Zhu J, Umans J. C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Diabetes Care 2008; 31: 2312-2314 [PMID: 18796618 DOI: 10.2337/dc08-0815]
80. Lutsey PL, Pankow JS, Bertoni AG, Szklo M, Folsom AR. Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis. Diabet Med 2009; 26: 149-152 [PMID: 19236617 DOI: 10.1111/j.1464-5491.2008.02632.x]
81. So WY, Tong PC, Ko GT, Ma RC, Ozaki R, Kong AP, Yang X, Ho CS, Lam CC, Chan JC. Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res Clin Pract 2009; 86: 89-95 [PMID: 19747747 DOI: 10.1016/j.diabres.2009.08.010]
82. Zhou X, Zhang C, Wu J, Zhang G. Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. Diabetes Res Clin Pract 2013; 99: 200-208 [PMID: 23395214 DOI: 10.1016/j.diabres.2012.11.012]
83. Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, Aiello AE. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012; 35: 520-525 [PMID: 22279028 DOI: 10.2337/dc11-1043]
84. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985; 9: 85-95 [PMID: 3915933]
85. Chung GE, Heo NJ, Park MJ, Chung SJ, Kang HY, Kang SJ. Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria. World J Gastroenterol 2013; 19: 97-102 [PMID: 23326169 DOI: 10.3748/wjg.v19.i1.97]
86. Yang X, Gao Y, Zhao X, Tang Y, Su Y. Chronic Helicobacter pylori infection and ischemic stroke subtypes. Neurol Res 2011; 33: 467-472 [PMID: 21669114 DOI: 10.1179/016164111 X13007856083963]
87. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996; 75: 568-572 [PMID: 8697158 DOI: 10.1136/ hrt.75.6.568]
88. Markus HS, Mendall MA. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 1998; 64: 104-107 [PMID: 9436737 DOI: 10.1136/jnnp.64.1.104]
89. Ashtari F, Shayegannejad V, Saberi A, Rabiee E. Relationship between Helicobacter pylori immunoglobulin G antibody and thrombotic ischemic stroke. Acta Med Iran 2008; 46: 303-306
90. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999; 131: 573-577 [PMID: 10523217 DOI: 10.7326/0003-4819-131-8-199910190-00004]
91. Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ, Bergamaschi A, Magrini A, Carrabs T, Vellini M, Galante A. Cytotoxin-associated gene-A - positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002; 106: 580-584 [PMID: 12147540 DOI: 10.1161/01.CIR.0000023894.10871.2F]
92. De Bastiani R, Gabrielli M, Ubaldi E, Benedetto E, Sanna G, Cottone C, Candelli M, Zocco MA, Saulnier N, Santoliquido A, Papaleo P, Gasbarrini G, Gasbarrini A. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter 2008; 13: 274-277 [PMID: 18665936 DOI: 10.1111/j.1523-5378.2008.00610.x]
93. Strauss EJ, Tejwani NC, Preston CF, Egol KA. The posterior Monteggia lesion with associated ulnohumeral instability. J Bone Joint Surg Br 2006; 88: 84-89 [PMID: 16365126 DOI: 10.1212/01.WNL.0000138025.82419.80]
94. Wang ZW, Li Y, Huang LY, Guan QK, Xu da W, Zhou WK, Zhang XZ. Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis. J Neurol 2012; 259: 2527-2537 [PMID: 22688569]
95. Gabrielli M, Santoliquido A, Cremonini F, Cicconi V, Candelli M, Serricchio M, Tondi P, Pola R, Gasbarrini G, Pola P, Gasbarrini A. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J 2004; 25: 64-68 [PMID: 14683744 DOI: 10.1016/ j.ehj.2003.10.004]
96. Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter 2007; 12: 298-305 [PMID: 17669101]
97. Strang RR. The Association of Gastro-Duodenal Ulceration and Parkinson's Disease. Med J Aust 1965; 1: 842-843 [PMID: 14313339]
98. Altschuler E. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy. Med Hypotheses 1996; 47: 413-414 [PMID: 8951807 DOI: 10.1016/S0306-9877(96)90223-6]
99. Bjarnason IT, Charlett A, Dobbs RJ, Dobbs SM, Ibrahim MA, Kerwin RW, Mahler RF, Oxlade NL, Peterson DW, Plant JM, Price AB, Weller C. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebocontrolled efficacy study. Helicobacter 2005; 10: 276-287 [PMID: 16104943 DOI: 10.1111/j.1523-5378.2005.00330.x]
100. Pierantozzi M, Pietroiusti A, Brusa L, Galati S, Stefani A, Lunardi G, Fedele E, Sancesario G, Bernardi G, Bergamaschi A, Magrini A, Stanzione P, Galante A. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations. Neurology 2006; 66: 1824-1829 [PMID: 16801644 DOI: 10.1212/01.wnl.0000221672.01272.ba]
101. Dobbs SM, Dobbs RJ, Weller C, Charlett A, Bjarnason IT, Lawson AJ, Letley D, Harbin L, Price AB, Ibrahim MA, Oxlade NL, Bowthorpe J, Leckstroem D, Smee C, Plant JM, Peterson DW. Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism. Helicobacter 2010; 15: 279-294 [PMID: 20633189 DOI: 10.1111/j.1523-5378.2010.00768.x]
102. Weller C, Charlett A, Oxlade NL, Dobbs SM, Dobbs RJ, Peterson DW, Bjarnason IT. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile. Helicobacter 2005; 10: 288-297 [PMID: 16104944 DOI: 10.1111/ j.1523-5378.2005.00329.x]
103. Dobbs RJ, Dobbs SM, Weller C, Charlett A, Bjarnason IT, Curry A, Ellis DS, Ibrahim MA, McCrossan MV, O'Donohue J, Owen RJ, Oxlade NL, Price AB, Sanderson JD, Sudhanva M, Williams J. Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter 2008; 13: 309-322 [PMID: 19250506 DOI: 10.1111/j.1523-5378.2008.00622.x]
104. Hunot S, Hirsch EC. Neuroinflammatory processes in Parkinson's disease. Ann Neurol 2003; 53 Suppl 3: S49-58; discussion S58-60 [PMID: 12666098 DOI: 10.1002/ana.10481]
105. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 2009; 5: 348-360 [PMID: 19560105 DOI: 10.1016/j.jalz.2008.12.001]
106. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006; 66: 938-940 [PMID: 16567719 DOI: 10.1212/01.wnl.0000203644.68059.5f]
107. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N, Tsolaki M, Chatzopoulos D, Katsinelos P, Tzilves D, Zabouri A, Michailidou I. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Int J Neurosci 2009; 119: 765-777 [PMID: 19326283 DOI: 10.1080/00207450902782083]
108. Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D, Venizelos I. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J Neurol 2009; 256: 758-767 [PMID: 19240960 DOI: 10.1007/s00415-009-5011-z]
109. Kountouras J, Mylopoulos N, Chatzopoulos D, Zavos C, Boura P, Konstas AG, Venizelos J. Eradication of Helicobacter pylori may be beneficial in the management of chronic openangle glaucoma. Arch Intern Med 2002; 162: 1237-1244 [PMID: 12038941 DOI: 10.1001/archinte.162.11.1237]
110. Malaguarnera M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Intern Med 2004; 15: 381-386 [PMID: 15522573 DOI: 10.1016/j.ejim.2004.05.008]
111. Hallam DM, Capps NL, Travelstead AL, Brewer GJ, Maroun LE. Evidence for an interferon-related inflammatory reaction in the trisomy 16 mouse brain leading to caspase- 1-mediated neuronal apoptosis. J Neuroimmunol 2000; 110: 66-75 [PMID: 11024535 DOI: 10.1016/S0165-5728(00)00289-7]
112. Charles A. The evolution of a migraine attack - a review of recent evidence. Headache 2013; 53: 413-419 [PMID: 23278169 DOI: 10.1111/head.12026]
113. Cutrer FM. Pathophysiology of migraine. Semin Neurol 2006; 26: 171-180 [PMID: 16628527 DOI: 10.1055/s-2006-939917]
114. Charles A. Vasodilation out of the picture as a cause of migraine headache. Lancet Neurol 2013; 12: 419-420 [PMID: 23578774 DOI: 10.1016/S1474-4422(13)70051-6]
115. Deleu D, Hanssens Y, Worthing EA. Symptomatic and prophylactic treatment of migraine: a critical reappraisal. Clin Neuropharmacol 1998; 21: 267-279 [PMID: 9789706]
116. Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB. The relative role of genetic and environmental factors in migraine without aura. Neurology 1999; 53: 995-999 [PMID: 10496258]
117. Yiannopoulou KG, Efthymiou A, Karydakis K, Arhimandritis A, Bovaretos N, Tzivras M. Helicobacter pylori infection as an environmental risk factor for migraine without aura. J Headache Pain 2007; 8: 329-333 [PMID: 18071631 DOI: 10.1007/s10194-007-0422-7]
118. Gasbarrini A, De Luca A, Fiore G, Franceschi F, Ojetti V V, Torre ES, Di Campli C, Candelli M, Pola R, Serricchio M, Tondi P, Gasbarrini G, Pola P, Giacovazzo M. Primary Headache and Helicobacter Pylori. Int J Angiol 1998; 7: 310-312 [PMID: 9716793 DOI: 10.1007/s005479900121]
119. Hong L, Zhao Y, Han Y, Guo W, Wang J, Li X, Han Y, Fan D. Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis. Helicobacter 2007; 12: 306-308 [PMID: 17669102 DOI: 10.1111/j.1523-5378.2007.00512.x]
120. Tunca A, Türkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A casecontrol study. Acta Neurol Belg 2004; 104: 161-164 [PMID: 15742606]
121. Hosseinzadeh M, Khosravi A, Saki K, Ranjbar R. Evaluation of Helicobacter pylori infection in patients with common migraine headache. Arch Med Sci 2011; 7: 844-849 [PMID: 22291830 DOI: 10.5114/aoms.2011.25560]
122. Pinessi L, Savi L, Pellicano R, Rainero I, Valfrè W, Gentile S, Cossotto D, Rizzetto M, Ponzetto A. Chronic Helicobacter pylori infection and migraine: a case-control study. Headache 2000; 40: 836-839 [PMID: 11135029 DOI: 10.1046/ j.1526-4610.2000.00151.x]
123. Caselli M, Chiamenti CM, Soriani S, Fanaro S. Migraine in children and Helicobacter pylori. Am J Gastroenterol 1999; 94: 1116-1118 [PMID: 10201507 DOI: 10.1111/j.1572- 0241.1999.1116a.x]
124. Mavromichalis I, Zaramboukas T, Giala MM. Migraine of gastrointestinal origin. Eur J Pediatr 1995; 154: 406-410 [PMID: 7641777 DOI: 10.1007/BF02072116]
125. Haberl H. Net land-atmosphere flows of biogenic carbon related to bioenergy: towards an understanding of systemic feedbacks. Glob Change Biol Bioenergy 2013; 5: 351-357 [PMID: 23956793 DOI: 10.1155/2013/436727.]
126. Ring J. Allergy in Practice. Berlin, Germany: Springer, 2005
127. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid- Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B, Maurer M. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426 [PMID: 19772512 DOI: 10.1111/ j.1398-9995.2009.02179.x]
128. Nichols KM, Cook-Bolden FE. Allergic skin disease: major highlights and recent advances. Med Clin North Am 2009; 93: 1211-1224 [PMID: 19932327 DOI: 10.1016/ j.mcna.2009.08.004]
129. Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004; 39: 827-830 [PMID: 15565400 DOI: 10.1007/s00535-004-1397-7]
130. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003; 49: 861-864 [PMID: 14576665 DOI: 10.1016/ S0190-9622(03)00846-6]
131. Daudén E, Jiménez-Alonso I, García-Díez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol 2000; 39: 446-452 [PMID: 10944090 DOI: 10.1046/j.1365-4362.2000.00995.x]
132. Moreira A, Rodrigues J, Delgado L, Fonseca J, Vaz M. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr) 2003; 31: 209-214 [PMID: 12890412 DOI: 10.1016/S0301-0546(03)79180-0]
133. Chiu YC, Tai WC, Chuah SK, Hsu PI, Wu DC, Wu KL, Huang CC, Ho JC, Ring J, Chen WC. The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria. Gastroenterol Res Pract 2013; 2013: 436727 [PMID: 23956739 DOI: 10.1155/2013/436727]
134. Goodgame RW, Malaty HM, el-Zimaity HM, Graham DY. Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection. Helicobacter 1997; 2: 44-47 [PMID: 9432322 DOI: 10.1111/j.1523-5378.1997.tb00057.x]
135. Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002; 3: 273-282 [PMID: 12010072 DOI: 10.2165/00128071-200203040-00005]
136. Bakos N, Fekete B, Prohászka Z, Füst G, Kalabay L. High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria. Allergy 2003; 58: 663-667 [PMID: 12823128 DOI: 10.1034/ j.1398-9995.2003.00200.x]
137. Powell FC. Clinical practice. Rosacea. N Engl J Med 2005; 352: 793-803 [PMID: 15728812 DOI: 10.1056/NEJMcp042829]
138. Elewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol 2011; 25: 188-200 [PMID: 20586834 DOI: 10.1111/j.1468-3083.2010.03751.x]
139. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010; 24: 565-571 [PMID: 19874433 DOI: 10.1111/j.1468-3083.2009.03472.x]
140. Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci 2009; 55: 77-81 [PMID: 19481425 DOI: 10.1016/ j.jdermsci.2009.04.007]
141. Bakar O, Demirc¸ay Z, Yuksel M, Haklar G, Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 2007; 32: 197-200 [PMID: 17244346 DOI: 10.1111/j.1365-2230.2006.02322.x]
142. Peus D, Vasa RA, Beyerle A, Meves A, Krautmacher C, Pittelkow MR. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J Invest Dermatol 1999; 112: 751-756 [PMID: 10233767 DOI: 10.1046/j.1523-1747.1999.00584.x]
143. Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol 1994; 89: 1603-1604 [PMID: 8079962]
144. Gürer MA, Erel A, Erbaş D, Caʇlar K, Atahan C. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol 2002; 41: 768-770 [PMID: 12452999 DOI: 10.1046/j.1365-4362.2002.01452.x]
145. Bagchi D, Bhattacharya G, Stohs SJ. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 1996; 24: 439-450 [PMID: 8804987 DOI: 10.3109/10715769609088043]
146. Mashimo M, Nishikawa M, Higuchi K, Hirose M, Wei Q, Haque A, Sasaki E, Shiba M, Tominaga K, Watanabe T, Fujiwara Y, Arakawa T, Inoue M. Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication. Helicobacter 2006; 11: 266-271 [PMID: 16882330 DOI: 10.1111/j.1523-5378.2006.00410.x]
147. Lazaridou E, Giannopoulou C, Fotiadou C, Vakirlis E, Trigoni A, Ioannides D. The potential role of microorganisms in the development of rosacea. J Dtsch Dermatol Ges 2011; 9: 21-25 [PMID: 21059171 DOI: 10.1111/j.1610-0387.2010.07513. x]
148. Sharma VK, Lynn A, Kaminski M, Vasudeva R, Howden CW. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol 1998; 93: 220-222 [PMID: 9468246 DOI: 10.1111/j.1572-0241.1998.00220.x]
149. Schneider M, Skinner RBJ, Rosenberg EW. Serological determination of Helicobacter pylori in rosacea patients and in controls. Clin Res 1992; 40: 831A
150. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002; 16: 328-333 [PMID: 12224687 DOI: 10.1046/j.1468-3083.2002.00497.x]
151. Utaş S, Ozbakir O, Turasan A, Utaş C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 1999; 40: 433-435 [PMID: 10071314]
152. Son SW, Kim IH, Oh CH, Kim JG. The response of rosacea to eradication of Helicobacter pylori. Br J Dermatol 1999; 140: 984-985 [PMID: 10354058 DOI: 10.1046/ j.1365-2133.1999.02852.x]
153. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 2011; 7: 518-527 [PMID: 21769128]
154. Dadabhoy D, Crofford LJ, Spaeth M, Russell IJ, Clauw DJ. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther 2008; 10: 211 [PMID: 18768089 DOI: 10.1186/ar2443]
155. Buskila D, Atzeni F, Sarzi-Puttini P. Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev 2008; 8: 41-43 [PMID: 18706528 DOI: 10.1016/j.ejr.2013.01.004]
156. Olama SM, El-Arman M. Helicobacter pylori in Egyptian patients with fibromyalgia syndrome. Egyptian Rheumatologist 2013; 35: 167-173
157. Akkaya N, Akkaya S, Polat Y, Turk M, Turk T, Turhal E, Sahin F. Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol 2011; 30: 43-49 [PMID: 21120564 DOI: 10.1007/s10067-010-1618-9]
158. Malt EA, Olafsson S, Ursin H. Fibromyalgia A manifestation of Helicobacter pylori infection? Scand J Rheumatol 2004; 33: 131 [DOI: 10.1080/03009740410006826-1468]